{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:26Z","timestamp":1792593686727,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82570191"],"award-info":[{"award-number":["No. 82570191"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07202-x","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:45:22Z","timestamp":1784929522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term hydroxyurea therapy alters bone marrow megakaryocyte morphology and associates with prognosis in myeloproliferative neoplasms"],"prefix":"10.1007","volume":"105","author":[{"given":"Zhikang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"5","key":"7202_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ajh.26857","volume":"98","author":"A Tefferi","year":"2023","unstructured":"Tefferi A (2023) Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 98(5):801\u2013821. https:\/\/doi.org\/10.1002\/ajh.26857","journal-title":"Am J Hematol"},{"issue":"3","key":"7202_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ajh.27184","volume":"99","author":"V Abbonante","year":"2024","unstructured":"Abbonante V, Karkempetzaki AI, Leon C, Krishnan A, Huang N, Di Buduo CA, Cattaneo D, Ward CM, Matsuura S, Guinard I, Weber J, De Acutis A, Vozzi G, Iurlo A, Ravid K, Balduini A (2024) Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis. Am J Hematol 99(3):336\u2013349. https:\/\/doi.org\/10.1002\/ajh.27184","journal-title":"Am J Hematol"},{"issue":"20","key":"7202_CR3","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1182\/blood.2022015418","volume":"141","author":"AJ Dunbar","year":"2023","unstructured":"Dunbar AJ, Kim D, Lu M, Farina M, Bowman RL, Yang JL, Park Y, Karzai A, Xiao W, Zaroogian Z, O\u2019Connor K, Mowla S, Gobbo F, Verachi P, Martelli F, Sarli G, Xia L, Elmansy N, Kleppe M, Chen Z, Xiao Y, McGovern E, Snyder J, Krishnan A, Hill C, Cordner K, Zouak A, Salama ME, Yohai J, Tucker E, Chen J, Zhou J, McConnell T, Migliaccio AR, Koche R, Rampal R, Fan R, Levine RL, Hoffman R (2023) CXCL8\/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis. Blood 141(20):2508\u20132519. https:\/\/doi.org\/10.1182\/blood.2022015418","journal-title":"Blood"},{"key":"7202_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exphem.2019.02.005","volume":"73","author":"H Kim","year":"2019","unstructured":"Kim H, Lee MK, Kim HR (2019) Difference in megakaryocyte expression of GATA-1, IL-6, and IL-8 associated with maintenance of platelet counts in patients with plasma cell neoplasm with dysmegakaryopoiesis. Exp Hematol 73:13\u201317e12. https:\/\/doi.org\/10.1016\/j.exphem.2019.02.005","journal-title":"Exp Hematol"},{"issue":"12","key":"7202_CR5","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.3324\/haematol.2020.264143","volume":"106","author":"M Schino","year":"2021","unstructured":"Schino M, Fiorentino V, Rossi E, Betti S, Di Cecca M, Ranucci V, Chiusolo P, Martini M, De Stefano V, Larocca LM (2021) Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms. Haematologica 106(12):3162\u20133169. https:\/\/doi.org\/10.3324\/haematol.2020.264143","journal-title":"Haematologica"},{"issue":"3","key":"7202_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000203671","volume":"97","author":"J Thiele","year":"1997","unstructured":"Thiele J, Lorenzen J, Manich B, Kvasnicka HM, Zirbes TK, Fischer R (1997) Apoptosis (programmed cell death) in idiopathic (primary) osteo-\/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematol 97(3):137\u2013143. https:\/\/doi.org\/10.1159\/000203671","journal-title":"Acta Haematol"},{"key":"7202_CR7","doi-asserted-by":"publisher","unstructured":"Zini G, Viscovo M (2021) Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates. Int J Lab Hematol 43(Suppl):123\u201328. https:\/\/doi.org\/10.1111\/ijlh.13536","DOI":"10.1111\/ijlh.13536"},{"issue":"7","key":"7202_CR8","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"issue":"14","key":"7202_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1182\/blood.2023021349","volume":"143","author":"I Crespiatico","year":"2024","unstructured":"Crespiatico I, Zaghi M, Mastini C, D\u2019Aliberti D, Mauri M, Mercado CM, Fontana D, Spinelli S, Crippa V, Inzoli E, Manghisi B, Civettini I, Ramazzotti D, Sangiorgio V, Gengotti M, Brambilla V, Aroldi A, Banfi F, Barone C, Orsenigo R, Riera L, Riminucci M, Corsi A, Breccia M, Morotti A, Cilloni D, Roccaro A, Sacco A, Stagno F, Serafini M, Mottadelli F, Cazzaniga G, Pagni F, Chiarle R, Azzoni E, Sessa A, Gambacorti-Passerini C, Elli EM, Mologni L, Piazza R (2024) First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood 143(14):1399\u20131413. https:\/\/doi.org\/10.1182\/blood.2023021349","journal-title":"Blood"},{"issue":"10","key":"7202_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3760\/cma.j.issn.0253-2727.2020.10.002","volume":"41","author":"ZX Shi","year":"2020","unstructured":"Shi ZX, Zhang PH, Li B, Fang LH, Xu ZF, Qin TJ, Liu JQ, Hu NB, Pan LJ, Qu SQ, Liu D, Xiao ZJ (2020) [Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations]. Zhonghua Xue Ye Xue Za Zhi 41(10):798\u2013805. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2020.10.002","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"7202_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13045-024-01562-5","volume":"17","author":"TR Haage","year":"2024","unstructured":"Haage TR, Charakopoulos E, Bhuria V, Baldauf CK, Korthals M, Handschuh J, M\u00fcller P, Li J, Harit K, Nishanth G, Frey S, B\u00f6ttcher M, Fischer KD, Dudeck J, Dudeck A, Lipka DB, Schraven B, Green AR, M\u00fcller AJ, Mougiakakos D, Fischer T (2024) Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia. J Hematol Oncol 17(1):43. https:\/\/doi.org\/10.1186\/s13045-024-01562-5","journal-title":"J Hematol Oncol"},{"issue":"1","key":"7202_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.14670\/hh-20.317","volume":"20","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM (2005) Diagnostic impact of bone marrow histopathology in polycythemia vera (PV). Histol Histopathol 20(1):317\u2013328. https:\/\/doi.org\/10.14670\/hh-20.317","journal-title":"Histol Histopathol"},{"issue":"11","key":"7202_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S, Bueso-Ramos CE, Cortes JE, Dal Cin P, DiNardo CD, Dombret H, Duncavage EJ, Ebert BL, Estey EH, Facchetti F, Foucar K, Gangat N, Gianelli U, Godley LA, Gokbuget N, Gotlib J, Hellstrom-Lindberg E, Hobbs GS, Hoffman R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh ML, Lowenberg B, Macintyre E, Malcovati L, Mullighan CG, Niemeyer C, Odenike OM, Ogawa S, Orfao A, Papaemmanuil E, Passamonti F, Porkka K, Pui CH, Radich JP, Reiter A, Rozman M, Rudelius M, Savona MR, Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, Dohner H, Tefferi A (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"issue":"1","key":"7202_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000517207","volume":"145","author":"G Barosi","year":"2022","unstructured":"Barosi G, Rosti V, Massa M, Campanelli R, Villani L, Catarsi P, Carolei A, Abba C, Lodigiani C, Primignani M, Gregato G, Bertolini F, Magrini U, Gale RP (2022) Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm. Acta Haematol 145(1):30\u201337. https:\/\/doi.org\/10.1159\/000517207","journal-title":"Acta Haematol"},{"issue":"7","key":"7202_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3324\/haematol.2014.118299","volume":"100","author":"C Al Assaf","year":"2015","unstructured":"Al Assaf C, Van Obbergh F, Billiet J, Lierman E, Devos T, Graux C, Hervent AS, Emmerechts J, Tousseyn T, De Paepe P, Papadopoulos P, Michaux L, Vandenberghe P (2015) Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations. Haematologica 100(7):893\u2013897. https:\/\/doi.org\/10.3324\/haematol.2014.118299","journal-title":"Haematologica"},{"issue":"25","key":"7202_CR16","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant\u2019Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Sch\u00f6negger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369(25):2379\u20132390. https:\/\/doi.org\/10.1056\/NEJMoa1311347","journal-title":"N Engl J Med"},{"issue":"4","key":"7202_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/bloodadvances.2018015875","volume":"2","author":"TL Lasho","year":"2018","unstructured":"Lasho TL, Mudireddy M, Finke CM, Hanson CA, Ketterling RP, Szuber N, Begna KH, Patnaik MM, Gangat N, Pardanani A, Tefferi A (2018) Targeted next-generation sequencing in blast phase myeloproliferative neoplasms. Blood Adv 2(4):370\u2013380. https:\/\/doi.org\/10.1182\/bloodadvances.2018015875","journal-title":"Blood Adv"},{"issue":"20","key":"7202_CR18","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1182\/bloodadvances.2018021469","volume":"2","author":"CJ McNamara","year":"2018","unstructured":"McNamara CJ, Panzarella T, Kennedy JA, Arruda A, Claudio JO, Daher-Reyes G, Ho J, Siddiq N, Devlin R, Tsui H, Su J, Stockley T, Sukhai M, Kanwar N, Chan S, Maze D, Schimmer A, Schuh A, Sibai H, Viswabandya A, Yee K, Minden MD, Kamel-Reid S, Gupta V (2018) The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes. Blood Adv 2(20):2658\u20132671. https:\/\/doi.org\/10.1182\/bloodadvances.2018021469","journal-title":"Blood Adv"},{"issue":"3","key":"7202_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/ajh.24973","volume":"93","author":"G Venton","year":"2018","unstructured":"Venton G, Courtier F, Charbonnier A, D\u2019Incan E, Saillard C, Mohty B, Mozziconacci MJ, Birnbaum D, Murati A, Vey N, Rey J (2018) Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms. Am J Hematol 93(3):330\u2013338. https:\/\/doi.org\/10.1002\/ajh.24973","journal-title":"Am J Hematol"},{"issue":"1","key":"7202_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/gcc.22789","volume":"59","author":"F Courtier","year":"2020","unstructured":"Courtier F, Garnier S, Carbuccia N, Guille A, Ad\u00e9laide J, Chaffanet M, Hirsch P, Luque Paz D, Slama B, Vey N, Ugo V, Delhommeau F, Rey J, Birnbaum D, Murati A (2020) Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes Chromosomes Cancer 59(1):30\u201339. https:\/\/doi.org\/10.1002\/gcc.22789","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"7202_CR21","doi-asserted-by":"publisher","first-page":"C177","DOI":"10.1152\/ajpcell.00328.2021","volume":"322","author":"M Stavnichuk","year":"2022","unstructured":"Stavnichuk M, Komarova SV (2022) Megakaryocyte-bone cell interactions: lessons from mouse models of experimental myelofibrosis and related disorders. Am J Physiol Cell Physiol 322(2):C177\u2013c184. https:\/\/doi.org\/10.1152\/ajpcell.00328.2021","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07202-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07202-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07202-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:01:45Z","timestamp":1792591305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07202-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7202"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07202-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9781240\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Clinical Research Ethics committee of First Affiliated Hospital, College of Medicine, Zhejiang University (Approval No. IIT20220199B). Informed consent was waived by the ethics committee due to the retrospective nature of this study using de-identified clinical data and specimens.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"471"}}